Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma
Author:
Funder
Janssen Research & Development
LLC
MSK Cancer Center
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/29/9/1995/25845253/mdy253.pdf
Reference22 articles.
1. Guidelines for the management of soft tissue sarcomas;Grimer;Sarcoma,2010
2. Prognostic factors and staging for soft tissue sarcomas: an update;Jones;Surg Oncol Clin N Am,2012
3. Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials;Cesne;Br J Cancer,2013
4. Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival;Garbay;Ann Oncol,2013
5. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients;Lahat;Ann Surg Oncol,2009
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic Nomograms for Elderly Patients with Small Cell Lung Cancer Brain Metastasis: A Surveillance, Epidemiology, and End Results Population-Based Study with Temporal External Validation;World Neurosurgery;2024-09
2. Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma;Clinical Cancer Research;2024-05-09
3. Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review;Critical Reviews in Oncology/Hematology;2024-05
4. Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms;Cancer Treatment Reviews;2024-04
5. Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13);Cancers;2024-01-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3